BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12506035)

  • 1. Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration.
    Dong R; Cwynarski K; Entwistle A; Marelli-Berg F; Dazzi F; Simpson E; Goldman JM; Melo JV; Lechler RI; Bellantuono I; Ridley A; Lombardi G
    Blood; 2003 May; 101(9):3560-7. PubMed ID: 12506035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes.
    Yasukawa M; Ohminami H; Kojima K; Hato T; Hasegawa A; Takahashi T; Hirai H; Fujita S
    Blood; 2001 Sep; 98(5):1498-505. PubMed ID: 11520800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.
    Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA
    Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein.
    Brown S; Hutchinson CV; Aspinall-O'Dea M; Whetton AD; Johnson SM; Rees-Unwin K; Burthem J
    Eur J Haematol; 2014 Aug; 93(2):96-102. PubMed ID: 24617663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells from patients with chronic myeloid leukemia: functional and phenotypic features.
    Eisendle K; Wolf D; Gastl G; Kircher-Eibl B
    Leuk Lymphoma; 2005 May; 46(5):663-70. PubMed ID: 16019503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].
    Zheng SE; Jin J; Tong XM; Qian WB; Xue YQ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):920-3. PubMed ID: 17533744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
    Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX
    Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors.
    Bhatia R; Munthe HA; Verfaillie CM
    Exp Hematol; 1999 Sep; 27(9):1384-96. PubMed ID: 10480429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo.
    Paquette RL; Hsu N; Said J; Mohammed M; Rao NP; Shih G; Schiller G; Sawyers C; Glaspy JA
    Leukemia; 2002 Aug; 16(8):1484-9. PubMed ID: 12145689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.
    Choudhury A; Gajewski JL; Liang JC; Popat U; Claxton DF; Kliche KO; Andreeff M; Champlin RE
    Blood; 1997 Feb; 89(4):1133-42. PubMed ID: 9028934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of dendritic cells from patients with chronic myelogenous leukemia.
    Heinzinger M; Waller CF; von den Berg A; Rosenstiel A; Lange W
    Ann Hematol; 1999 Apr; 78(4):181-6. PubMed ID: 10348149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells.
    Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF
    Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a p210(BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitro.
    Sun JY; Krouse RS; Forman SJ; Senitzer D; Sniecinski I; Chatterjee S; Wong KK
    Cancer Res; 2002 Jun; 62(11):3175-83. PubMed ID: 12036931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells.
    Mumprecht S; Claus C; Schürch C; Pavelic V; Matter MS; Ochsenbein AF
    Blood; 2009 May; 113(19):4681-9. PubMed ID: 19252140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells.
    Engels FH; Koski GK; Bedrosian I; Xu S; Luger S; Nowell PC; Cohen PA; Czerniecki BJ
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10332-7. PubMed ID: 10468608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR/ABL induces multiple abnormalities of cytoskeletal function.
    Salgia R; Li JL; Ewaniuk DS; Pear W; Pisick E; Burky SA; Ernst T; Sattler M; Chen LB; Griffin JD
    J Clin Invest; 1997 Jul; 100(1):46-57. PubMed ID: 9202056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological features of dendritic cells derived from chronic myeloid leukemia cells in vitro].
    Tong XM; Jin J; Qian WB; Meng HT; Xue YQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 34(4):348-52, 357. PubMed ID: 16059984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment.
    Gabriele L; Borghi P; Rozera C; Sestili P; Andreotti M; Guarini A; Montefusco E; Foà R; Belardelli F
    Blood; 2004 Feb; 103(3):980-7. PubMed ID: 14525781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rho-ROCK pathway as a new pathological mechanism of innate immune subversion in chronic myeloid leukaemia.
    Basbous S; Levescot A; Piccirilli N; Brizard F; Guilhot F; Roy L; Bourmeyster N; Gombert JM; Herbelin A
    J Pathol; 2016 Nov; 240(3):262-268. PubMed ID: 27513300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.